Director / PDMR shareholding

November 8, 2018

Download full announcement

Renalytix AI plc (AIM: RENX), a developer of artificial intelligence (“AI”) enabled clinical diagnostic solutions for kidney disease, announces that it was yesterday notified that on 6 November 2018 the following PDMR undertook a transaction in the ordinary shares of 0.25 pence each in the capital of the Company (“Ordinary Shares”), at a price of 120 pence per Ordinary Share:

  Number of Ordinary Shares bought Resultant Interest in Ordinary Shares Resultant Interest in Ordinary Shares (%)
James McCullough
Chief Executive Officer
16,150 2,870,110 5.33

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them


1 Details of the person discharging managerial responsibilities / person closely associated
a) Name James R. McCullough
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Renalytix AI plc
b) LEI 213800NTOH3FK3WER551
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 0.25 pence each
Identification code GB00BYWL4Y04
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
120 pence 16,150
d) Aggregated information n/a
– Aggregated volume  
– Price  
e) Date of the transaction 06 November 2018
f) Place of the transaction London Stock Exchange


Renalytix AI plc


James McCullogh, CEO
Tel: 00 44 29 2071 0570Via Walbrook PR or Tel: +1 646 397 3970
N+1 Singer (Nominated Adviser & Broker)


Aubrey Powell / Lauren Kettle / George Tzimas (Corporate Finance)
Tom Salvesen (Corporate Broking)

Tel: 020 7496 3000
Walbrook PR Limited
Paul McManus
Lianne Cawthorne
Tel: 020 7933 8780 or
Mob: 07980 541 893 / 07584 391 303